5-(3-Chloro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline

ID: ALA78310

PubChem CID: 10378955

Max Phase: Preclinical

Molecular Formula: C17H13ClN2

Molecular Weight: 280.76

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Clc1cccc(C2=Cc3ccccc3C3=NCCN23)c1

Standard InChI:  InChI=1S/C17H13ClN2/c18-14-6-3-5-13(10-14)16-11-12-4-1-2-7-15(12)17-19-8-9-20(16)17/h1-7,10-11H,8-9H2

Standard InChI Key:  ONPNIDSLTDIICC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 23  0  0  0  0  0  0  0  0999 V2000
    3.7667   -2.7375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2542   -3.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8042   -2.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2917   -1.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7417   -2.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2542   -3.6417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7542   -2.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4042   -2.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7000   -2.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2917   -3.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2917   -3.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3000   -2.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4542   -3.2500    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.6917   -1.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2042   -3.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2417   -1.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2917   -1.6292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5917   -2.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6917   -2.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7125   -2.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  3  2  0
  5  2  1  0
  6  2  2  0
  7  4  1  0
  8  3  1  0
  9  8  2  0
 10  1  1  0
 11 10  1  0
 12  9  1  0
 13 12  1  0
 14  8  1  0
 15  5  1  0
 16  7  1  0
 17 14  2  0
 18 17  1  0
 19 15  2  0
 20 16  2  0
  6 11  1  0
  5  7  2  0
 12 18  2  0
 20 19  1  0
M  END

Associated Targets(Human)

PTAFR Tchem Platelet activating factor receptor (2575 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Abelson 8.1 (129 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 280.76Molecular Weight (Monoisotopic): 280.0767AlogP: 3.91#Rotatable Bonds: 1
Polar Surface Area: 15.60Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.09CX LogP: 3.66CX LogD: 3.49
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.77Np Likeness Score: -0.58

References

1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA..  (1995)  Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines.,  38  (2): [PMID:7830265] [10.1021/jm00002a004]

Source